File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Management of Hypertension and Cardiovascular (CV) Diseases with Angiotensin II Receptor Blockers
| Title | Management of Hypertension and Cardiovascular (CV) Diseases with Angiotensin II Receptor Blockers |
|---|---|
| Authors | |
| Issue Date | 2011 |
| Publisher | Hong Kong College of Family Physicians. |
| Citation | The 1st Hong Kong Primary Care Conference (HKPCC), Hong Kong, 28-29 May 2011 How to Cite? |
| Abstract | The favorable tolerability profiles of angiotensin II receptor blockers (ARBs) make them an attractive
treatment option for hypertension. Is there any other evidence indicating additional benefit of ARBs beside BP control? What is the evidence for using ARBs in hypertension and CV diseases compared to other therapeutic options? Should we consider ARBs as first line anti-hypertensive agents? If yes, in which type of patients? Prof. Tse Hung Fat, William MW Mong Professor in Cardiology, Director of Sun Chieh Yeh Cardiovascular Research and Training Laboratory, HKU and Deputy Director of Institute of Cardiovascular Science and Medicine, Department of Medicine (HKU), will share with us the latest evidence on using ARBs for the management of hypertension and CV diseases during our lunch symposium. Prof. Tse has more than 200 publications in prestigious journals including the Lancet on various cardiovascular topics including the management of atrial fibrillation and the angiogenesis in ischaemic myocardium. |
| Description | Invited Speaker |
| Persistent Identifier | http://hdl.handle.net/10722/254335 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tse, HF | - |
| dc.date.accessioned | 2018-06-14T06:42:16Z | - |
| dc.date.available | 2018-06-14T06:42:16Z | - |
| dc.date.issued | 2011 | - |
| dc.identifier.citation | The 1st Hong Kong Primary Care Conference (HKPCC), Hong Kong, 28-29 May 2011 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/254335 | - |
| dc.description | Invited Speaker | - |
| dc.description.abstract | The favorable tolerability profiles of angiotensin II receptor blockers (ARBs) make them an attractive treatment option for hypertension. Is there any other evidence indicating additional benefit of ARBs beside BP control? What is the evidence for using ARBs in hypertension and CV diseases compared to other therapeutic options? Should we consider ARBs as first line anti-hypertensive agents? If yes, in which type of patients? Prof. Tse Hung Fat, William MW Mong Professor in Cardiology, Director of Sun Chieh Yeh Cardiovascular Research and Training Laboratory, HKU and Deputy Director of Institute of Cardiovascular Science and Medicine, Department of Medicine (HKU), will share with us the latest evidence on using ARBs for the management of hypertension and CV diseases during our lunch symposium. Prof. Tse has more than 200 publications in prestigious journals including the Lancet on various cardiovascular topics including the management of atrial fibrillation and the angiogenesis in ischaemic myocardium. | - |
| dc.language | eng | - |
| dc.publisher | Hong Kong College of Family Physicians. | - |
| dc.relation.ispartof | Hong Kong Primary Care Conference (HKPCC), 2011 | - |
| dc.title | Management of Hypertension and Cardiovascular (CV) Diseases with Angiotensin II Receptor Blockers | - |
| dc.type | Conference_Paper | - |
| dc.identifier.email | Tse, HF: hftse@hkucc.hku.hk | - |
| dc.identifier.authority | Tse, HF=rp00428 | - |
| dc.identifier.hkuros | 204038 | - |
| dc.publisher.place | Hong Kong | - |